Laurus Labs IPO GMP History
Laurus Labs IPO has been listed on December 19, 2016 at a listing price of ₹489.9, against the issue price of ₹428 — a gain of ₹61.9 (+14.46%). The day-wise GMP trend below shows how grey market sentiment evolved from subscription to listing.
Laurus Labs IPO raised ₹1330.51 Cr. through its IPO at a price band of ₹426 to ₹428 per share, with a lot size of 35 shares. The IPO was open for subscription from 06 Dec 2016 to 08 Dec 2016.
Researched & reviewed by
Abhishek Vohera,
Founder, IPO Guru
Last updated
Figures sourced from the RHP, BSE & NSE
GMP trend
Grey market premium sampled three times a day (11 AM, 5 PM, 10 PM). Last updated 12 Nov, 3:11 PM IST.
Day-wise GMP
The last reading of each day, newest first. Arrows compare with the previous day.
| Date | GMP | ↑↓ | % | Kostak | Sub. Sauda |
|---|---|---|---|---|---|
| No GMP history available yet. | |||||
Laurus Labs IPO dates
Key dates from opening to listing. Today is 14 November.
- Open 06 Dec 2016
- Close 08 Dec 2016
- Allotment 14 Dec 2016
- Refund/credit 15 Dec 2016
- Listing 19 Dec 2016
Laurus Labs IPO actual listing price
How the grey market's final call compared with the listing-day open.
| Issue price | ₹428 |
|---|---|
| Listing gain / loss | +₹61.9 per share |
| Listing date | 19 Dec, 2016 |
| Actual listing price | ₹489.9 (+14.46%) |
Is Laurus Labs IPO GMP reliable?
Grey market premium for Laurus Labs IPO should be interpreted with caution. The GMP is an unregulated, unofficial market not governed by SEBI. Here's how to read the current signal:
- 01Subscription rate matters: A high GMP paired with strong subscription — especially QIB (Qualified Institutional Buyer) oversubscription — is a more reliable bullish signal than GMP alone. Read our in-depth analysis: GMP vs Subscription Data — Which Predicts Listing Gains Better?
- 02Timing matters: GMP in the first 1–2 days of subscription is less reliable. GMP on the final subscription day and the day before listing tends to be the most accurate predictor.
- 03Grey market is thin: For smaller IPOs, even a handful of large orders can swing the GMP significantly. Treat low-volume GMP signals with extra caution.
- 04Cross-check before acting: Review the Laurus Labs IPO full review for a fundamentals-based assessment before making any grey market trades.
Laurus Labs IPO Kostak rate explained
Two ways the grey market trades an IPO application before listing.
The Kostak rate for Laurus Labs IPO was not available during the subscription period. Kostak is the fixed amount a grey market buyer pays for an IPO application regardless of allotment outcome.
The Subject to Sauda price was not available for this IPO. Subject to Sauda only applies if allotment is confirmed — the buyer pays a premium on top of the issue price per lot allotted.
Grey market trading is unofficial and unregulated by SEBI. Proceed with full awareness of the associated risks.
About Laurus Labs IPO
Laurus Labs Limited is a Hyderabad based pharmaceutical company. Its promoters include Satyanarayana Chava and Naga Rani Chava.
It makes generic active pharmaceutical ingredients for antiretrovirals and Hepatitis C, and APIs in oncology and other therapeutic areas.
It operates across four business lines, starting with generic APIs.
The IPO was Rs 1,330.51 crore, with Rs 299.71 crore of fresh issue and Rs 1,030.80 crore of offer for sale, at Rs 428, the top of the Rs 426 to Rs 428 band. Most of the fresh money was for prepaying term loans.
Frequently asked
What is the GMP of Laurus Labs IPO?
The current Grey Market Premium (GMP) of Laurus Labs IPO is not yet started or active in the market.
What is the Kostak Price of Laurus Labs IPO?
Kostak rate is the profit made by selling an IPO application before allotment. The current Kostak rate for Laurus Labs IPO is not available.
What is the Subject to Sauda Price of Laurus Labs IPO?
Subject to Sauda is the premium amount decided if the allotment is confirmed. The current Subject to Sauda rate is not available.
What was the actual listing price of Laurus Labs IPO?
Laurus Labs IPO listed on December 19, 2016 at ₹489.9, against the issue price of ₹428 — a gain of +14.46%.
How did the GMP of Laurus Labs IPO trend before listing?
The GMP of Laurus Labs IPO was stable in its final days before listing. View the day-wise table above for the complete GMP history.
Explore Laurus Labs IPO further
The grey market is one signal. Read it alongside the demand, the reviews and the filings before you decide.
It has listed — go back to the fundamentals.
Category-wise demand from QIB, NII and retail investors, updated through the day.
What brokers and analysts are saying about this issue, in one place.
Check with your PAN whether shares were credited to your demat account.
The grey market called it. Now check the fundamentals.
IPO Guru tracks GMP, subscription and allotment for every Mainboard and SME issue. Read the grey market alongside the subscription book and the offer document before you apply.
Not investment advice. Grey market premium is an unofficial, unregulated indicator and is not a forecast.
